CDMO Growth PrimaPharma operates as a contract development and manufacturing organization with capabilities in aseptic fill and finish for injectables and ophthalmics, and plans to add Blow Fill Seal and automated syringe/vial filling in 2016, indicating expansion opportunities in production capacity and advanced packaging.

Regulatory Readiness The company is ISO 13485 certified and regularly inspected by the FDA, highlighting a strong quality management framework that can be leveraged when pitching for new sterile or medical device collaborations with regulated markets.

Quality Leadership Recent personnel expansion in quality assurance leadership (associate Director of PrimaPharma Quality Assurance Department) signals a strategic emphasis on strengthening compliance, documentation, and audit readiness for new client programs.

Market Fit With a focus on prescription and over-the-counter drugs, medical devices, and clinical trial materials, PrimaPharma serves a broad CDMO need set that aligns with clients seeking end-to-end manufacturing, sterile fill-finish, and regulatory-savvy partners.

Scale & Finance Reported revenue range of 10 to 25 million and a mid-sized employee base suggest opportunities to upsell higher-volume sterile manufacturing, process optimization projects, or expanded service lines to mid-market pharma and biotech sponsors.